Global Artificial Kidney Market Overview:
Growing geriatric population, increasing disposable income and rising life expectancy are expected to boost the market of Artificial Kidney Market. Kidney disease is the 9th leading cause of death in the country. According to the National Kidney Foundation around 10% of the population is suffering from chronic kidney diseases globally. Artificial Kidney refers to a device used to filter the blood of the person suffering from kidney damage. It is also known as haemodialyzer. The artificial kidney replicates the work of real kidney and eliminated the need of for dialysis. It helps to produce the hormone, regulate blood pressure, promote red cell and support bone health. It reduces the kidney disease and allows the patient to stay quality life. Some of the key players profiled in the study are Baxter International Inc. (United States), Xcorporeal Inc. (United States), Medtronic, (United States), DaVita Inc. (United States), Merit Medical Systems, Inc. (United States), NIPRO Medical Corporation (United States), NxStage (United States), SynCardia Systems (United States), B. Braun Melsungen AG (Germany) and Fresenius (Germany).
On the basis of geography, the market of Artificial Kidney has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder
- Rising In the Disposable Income
- Rise in Number of People Awaiting Organ Transplant
- Technology Advancement in Field Of Science
- High Cost of Artificial Kidney Hamper Broader Adoption
- Growing Awareness about Artificial Kidney
- Lack of Surgical Expertise
Major Market Developments:
According to the National Kidney Foundation, " Around 10% of the population are suffering from chronic kidney diseases globally. About two million patients are either under the treatment of dialysis or need a kidney transplant to stay alive." In the global geriatric population, age between 65 to 74, it is predicted that one in five men and one in four women are suffering from chronic kidney diseases. About more than 30 Million American diseases.
FDA approves the clinical testing of a wearable artificial kidney developed by the University of Washington Medical Center. Going forward, wearable artificial kidney systems are expected to be portable, lightweight, user-friendly, smaller, and more convenient.
Target Audience:Artificial Kidney Manufacturers, Artificial Kidney Distributors/Traders/Wholesalers, Artificial Kidney Subcomponent Manufacturers, Industry Association and Downstream Vendors
Major Objectives Focused through this Study To define, describe, and forecast the Global Artificial Kidney market on the basis of product [Wearable Artificial Kidney and Implantable Artificial Kidney] , application [Adults and Pediatrics], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Artificial Kidney market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Artificial Kidney industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Kawasumi Laboratories, Inc. (Japan), Nikkiso Co. Ltd. (Japan) and Asahi Kasei Medical Vo., Ltd. (Japan).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Artificial Kidney market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.